Fund Holdings — ORACLE INVESTMENT MANAGEMENT INC

Total Portfolio Value:
$125.12M
Total Bought:
$26.06M
Total Sold:
$27.14M
Net Transaction:
-$1.08M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
GeneDx Holdings Corp.CL A(WGS)1,105,7681,045,768-60,000$28.90M$44.38M35.47%+$15.48M
Biohaven Ltd.(BHVN)700,450705,250+4,800$24.31M$35.24M28.17%+$10.93M
Phathom Pharmaceuticals, Inc.(PHAT)225,000749,487+524,487$2.32M$13.55M10.83%+$11.23M
Ardelyx Inc1,488,1311,369,200-118,931$11.03M$9.43M7.54%-$1.59M
QuidelOrtho Corporation(QDEL)118,291118,2910$3.93M$5.39M4.31%+$1.46M
BioCryst Pharmaceuticals, Inc.(BCRX)535,558535,5580$3.31M$4.07M3.25%+$760.5K
Myriad Genetics, Inc.(MYGN)60,000134,500+74,500$1.47M$3.68M2.94%+$2.22M
Forian Inc
COM
1,356,1071,356,1070$3.59M$2.93M2.34%-$664.5K
CAVA Group, Inc.(CAVA)18,60018,6000$1.73M$2.30M1.84%+$578.5K
Pacific Biosciences of California, Inc.(PACB)423,138727,877+304,739$579.7K$1.24M0.99%+$657.7K
Springworks Therapeutics Inc233,20034,200-199,000$8.78M$1.10M0.88%-$7.69M
Palantir Technologies Inc.CL A(PLTR)027,500+27,500$0$1.02M0.82%+$1.02M
Biogen Inc.(BIIB)2,4122,4120$559.1K$467.5K0.37%-$91.6K
EyePoint, Inc.(EYPT)231,85732,500-199,357$2.02M$259.7K0.21%-$1.76M
Biodesix, Inc.(BDSX)28,91628,9160$44.2K$51.5K0.04%+$7.2K
Agenus Inc.(AGEN)17,5000-17,500$293.1K$0—-$293.1K
Walgreens Boots Alliance Inc27,5000-27,500$332.6K$0—-$332.6K
Page 1 of 1
ORACLE INVESTMENT MANAGEMENT INC — 13F Holdings — Q3 2024 | TickerTrail